Star Therapeutics Raises $200 Million to Push Preclinical Drugs Into Clinic
Star Therapeutics raised $200 million co-led by OrbiMed and Janus Henderson, months after Incyte paid up to $2 billion for its Vega subsidiary.
Topic
Drug Development
Topic
Topic
Topic
Star Therapeutics raised $200 million co-led by OrbiMed and Janus Henderson, months after Incyte paid up to $2 billion for its Vega subsidiary.